MedTrace Logo

Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients

NCT00357955 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2024-11-07

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to study whether a multidisciplinary education in Diabetes and intervention for cardiac risk reduction in a group setting to modify patient behavior and adjust medications can achieve diabetes guideline goals for glycemia, blood pressure and lipid control.

Conditions

Interventions

BEHAVIORAL

Behavioral counseling and peer support

Multidisciplinary education and diabetes intervention for cardiac risk reduction - pharmacist led group intervention

BEHAVIORAL

Interactive Education

interactive lectures with hands-on learning

BEHAVIORAL

Role modeling

learning from peers with similar disease and problems

PROCEDURE

Pharmacologic case management

provided by clinical pharmacists following pre-established algorithms

Sponsors & Collaborators

  • Rhode Island Foundation

    collaborator OTHER

  • Providence VA Medical Center

    lead FED

Principal Investigators

  • Wen-Chih Wu, MD · Providence VAMC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00357955 on ClinicalTrials.gov